February 9, 2016
Quanterix announces that Analytical Chemistry, a leading peer-reviewed scientific journal, has published a truly groundbreaking new study authored by Dr. David Walt of Tufts University that prominently features Quanterix’s Single Molecule Array Detection technology, Simoa.
August 1, 2016
Quanterix announces a license agreement for research use with Banyan Biomarkers, a pioneering company in the development of biomarkers for traumatic brain injury (TBI).
January 9, 2017
Investment in new products, menu and globalization coupled with 60 percent revenue growth positions Quanterix for a “breakout” 2017; CEO wins Healthcare Innovation All-Star Award
EY Announces Kevin Hrusovsky, Executive Chairman and Chief Executive Officer of Quanterix, as an Entrepreneur Of The Year® New England 2017 Finalist
June 26, 2017
Kevin Hrusovsky, Executive Chairman and CEO of Quanterix is a finalist for the Entrepreneur Of The Year® 2017 Award in the New England program. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and…